ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
97,998.44
0.22%
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs Yen
154.77
0.00%
Brent Oil
74.65
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Mei Pharma, Inc. (MM) (MSHL)

  7. Mei Pharma, Inc. (MM) (MSHL) ニュース

MSHL

Marshall Edwards (MSHL)

Mei Pharma, Inc. (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MSHL
日付受信時刻ニュースソース見出しコード企業名
2012/07/1003 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/07/0605 : 03Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/07/0304 : 18Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/06/2822 : 00PR Newswire (US)Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/06/0619 : 04Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/06/0606 : 28Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/06/0422 : 00PR Newswire (US)Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/2922 : 00PR Newswire (US)Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/2602 : 32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/1604 : 27Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/1602 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/1602 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/1602 : 11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/1523 : 05Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/1422 : 00PR Newswire (US)Marshall Edwards Completes Rights Offering To StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
2012/05/0822 : 00PR Newswire (US)Marshall Edwards Receives $4 Million Subscription From Novogen In Rights OfferingNASDAQ:MSHLMei Pharma, Inc. (MM)
2012/04/2522 : 00PR Newswire (US)Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating CancerNASDAQ:MSHLMei Pharma, Inc. (MM)
2012/04/1404 : 59Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/04/1203 : 41Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/04/1022 : 00PR Newswire (US)Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/04/0322 : 00PR Newswire (US)Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual MeetingNASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/3101 : 34Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/3101 : 32Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/2822 : 00PR Newswire (US)Marshall Edwards CEO to Present at Needham Healthcare ConferenceNASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/2722 : 00PR Newswire (US)Marshall Edwards Receives Notice of Effectiveness for Rights Offering to StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/2719 : 02Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/2705 : 40Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/2021 : 55Edgar (US Regulatory)Securities Registration Statement (S-1/A)NASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/1922 : 00PR Newswire (US)Marshall Edwards Announces Terms for Rights Offering to StockholdersNASDAQ:MSHLMei Pharma, Inc. (MM)
2012/03/0802 : 17Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MSHLMei Pharma, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:MSHL

最近閲覧した銘柄

COIN
ADAUSD
Cardano
CCOM
SILVER
SILVER
NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
USOTC
ADDYY
Adidas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
AVAXUSD
Avalanche
COIN
DOGEUSD
Dogecoin
NYSE
CVX
Chevron
COIN
XRPUSD
Ripple
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有